Santen is a leading multinational company that specializes in ophthalmology. President and Head for Europe, Middle East and Africa (EMEA) Luis Iglesias highlights the company’s recent transformation through partnerships across a vast array of areas including digital technology and cell and gene. He also discusses how Santen has leveraged its acquisition of MSD’s ophthalmology portfolio, and how the vision of their CEO, Shigeo Taniuchi, has permeated throughout the organization.
Our CEO, all my colleagues at corporate officer level, and I, want to make Santen a global company. We are going to do it the Santen way, with patience, professionalism and true innovation
